Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Scientific Reports
|
February 14, 2025
Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis
Marcelo Fernando do Nascimento, Ludmila Rodrigues Pinto Ferreira, José Mauro Vieira Junior, et al.
Viruses
|
November 25, 2023
Patterns of Circulating Cytokines and Vascular Markers' Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients
Milena Karina Coló Brunialti, Giuseppe G F Leite, Gabriela Strafolino Eburneo, et al.
Pharmacological Research
|
May 10, 2019
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis
Akbar Ahmad, Juliana de Camargo Vieira, Aline Haas de Mello, et al.
JCI Insight
|
February 4, 2025
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
Manu Shankar-Hari, Bruno Francois, Kenneth E Remy, et al.
Shock (Augusta, Ga.)
|
February 27, 2014
Abandon the mouse research ship? Not just yet!
Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Scientific Reports
|
February 14, 2025
Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis
Marcelo Fernando do Nascimento, Ludmila Rodrigues Pinto Ferreira, José Mauro Vieira Junior, et al.
Viruses
|
November 25, 2023
Patterns of Circulating Cytokines and Vascular Markers' Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients
Milena Karina Coló Brunialti, Giuseppe G F Leite, Gabriela Strafolino Eburneo, et al.
Pharmacological Research
|
May 10, 2019
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis
Akbar Ahmad, Juliana de Camargo Vieira, Aline Haas de Mello, et al.
JCI Insight
|
February 4, 2025
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
Manu Shankar-Hari, Bruno Francois, Kenneth E Remy, et al.
Shock (Augusta, Ga.)
|
February 27, 2014
Abandon the mouse research ship? Not just yet!
Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
Page
of 6